| Appetite-suppressant drugs and the risk of primary pulmonary hypertension L Abenhaim, Y Moride, F Brenot, S Rich, J Benichou, X Kurz, ... New England Journal of Medicine 335 (9), 609-616, 1996 | 1599 | 1996 |
| Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study E Bruckert, G Hayem, S Dejager, C Yau, B Bégaud Cardiovascular drugs and therapy 19, 403-414, 2005 | 1539 | 2005 |
| Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia S Picard, K Titier, G Etienne, E Teilhet, D Ducint, MA Bernard, R Lassalle, ... Blood 109 (8), 3496-3499, 2007 | 744 | 2007 |
| Benzodiazepine use and risk of Alzheimer’s disease: case-control study SB De Gage, Y Moride, T Ducruet, T Kurth, H Verdoux, M Tournier, ... Bmj 349, g5205, 2014 | 701 | 2014 |
| Use of oral corticosteroids in the United Kingdom TP Van Staa, HGM Leufkens, L Abenhaim, B Begaud, B Zhang, C Cooper Qjm 93 (2), 105-111, 2000 | 644 | 2000 |
| Admissions to hospital caused by adverse drug reactions: cross sectional incidence study P Pouyanne, F Haramburu, JL Imbs, B Bégaud Bmj 320 (7241), 1036, 2000 | 593 | 2000 |
| Benzodiazepine use and risk of dementia: prospective population based study SB de Gage, B Bégaud, F Bazin, H Verdoux, JF Dartigues, K Pérès, ... Bmj 345, 2012 | 585 | 2012 |
| Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France B Bégaud, JC Evreux, J Jouglard, G Lagier Thérapie (Paris) 40 (2), 111-118, 1985 | 585 | 1985 |
| Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France B Bégaud, JC Evreux, J Jouglard, G Lagier Therapie 40 (2), 111-118, 1985 | 464 | 1985 |
| Under-reporting of adverse drug reactions Estimate based on a spontaneous reporting scheme and a sentinel system: Estimate based on a spontaneous reporting scheme and a … A Alvarez-Requejo, A Carvajal, B Begaud, Y Moride, T Vega, LHM Arias European journal of clinical pharmacology 54, 483-488, 1998 | 358 | 1998 |
| Under‐reporting of adverse drug reactions in general practice Y Moride, F Haramburu, AA Requejo, B Begaud British journal of clinical pharmacology 43 (2), 177-181, 1997 | 298 | 1997 |
| Antipsychotic prescribing trends: a review of pharmaco‐epidemiological studies H Verdoux, M Tournier, B Begaud Acta Psychiatrica Scandinavica 121 (1), 4-10, 2010 | 280 | 2010 |
| Adverse drug reaction monitoring: doing it the French way N Moore, G Paux, B Begaud, M Biour, E Loupi, F Boismare, RJ Royer The Lancet 326 (8463), 1056-1058, 1985 | 253 | 1985 |
| Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability R Lagnaoui, N Moore, J Fach, M Longy-Boursier, B Begaud European journal of clinical pharmacology 56, 181-186, 2000 | 248 | 2000 |
| Causality assessment in pharmacovigilance: the French method and its successive updates G Miremont-Salamé, H Théophile, F Haramburu, B Bégaud Therapies 71 (2), 179-186, 2016 | 225 | 2016 |
| Patterns and correlates of benzodiazepine use in the French general population R Lagnaoui, F Depont, A Fourrier, A Abouelfath, B Begaud, H Verdoux, ... European journal of clinical pharmacology 60, 523-529, 2004 | 217 | 2004 |
| Rates of spontaneous reporting of adverse drug reactions in France B Bégaud, K Martin, F Haramburu, N Moore Jama 288 (13), 1588-1588, 2002 | 216 | 2002 |
| Benzodiazepine use in an elderly community-dwelling population: characteristics of users and factors associated with subsequent use A Fourrier, L Letenneur, J Dartigues, N Moore, B Bégaud European journal of clinical pharmacology 57, 419-425, 2001 | 205 | 2001 |
| Differences between clinical trials and postmarketing use K Martin, B Bégaud, P Latry, G Miremont‐Salamé, A Fourrier, N Moore British journal of clinical pharmacology 57 (1), 86-92, 2004 | 202 | 2004 |
| Psychotropic drugs use and risk of heat-related hospitalisation K Martin-Latry, MP Goumy, P Latry, C Gabinski, B Bégaud, I Faure, ... European Psychiatry 22 (6), 335-338, 2007 | 176 | 2007 |
